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A  systemic  graft-vs.-host  reaction  (GVHR) 1  can  give  rise  to  a  variety  of 
pathological  symptoms.  One  of the  possible  outcomes  is  acute  GVH  disease 
(GVHD). After a brief initial phase of lymphoid stimulation (1-3), 2 acute GVHD 
rapidly produces  suppressive  pathological  symptoms,  such as  pancytopenia ac- 
companied by aplastic anemia and hypogammaglobulinemia (1-7). 2 A  different 
possible consequence of the GVHR consists of long-term stimulatory pathological 
symptoms and is referred to as chronic GVHD (8). This type of GVHD comprises 
a  persistent lymphoid hyperplasia (I-3,  6,  9), 2 hypergammaglobulinemia (1,  7, 
9,  10), and the formation of autoantibodies and pathological lesions reminiscent 
of systemic lupus erythematosus (SLE) or other types of vascular collagen disease 
(1-3,  7-10).  Either type of GVHD can be experimentally induced by injecting 
parental strain T  lymphocytes into nonirradiated F1 hybrid mice. Which type of 
GVHD will develop in these GVH F1  mice appears to depend on the subset of 
donor T  cells activated in them (2,  3,  7,  1 1). 2 The stimulatory GVH symptoms 
can  be  induced  by  Lyt-l+2--alloreactive donor  T  helper  (Th)  cells,  whereas 
induction  of the  suppressive  GVH symptoms requires both  alloreactive donor 
Th and T  suppressor (Ts) cells (3,  1 1). 2 The alloactivated donor Ts cells, which 
might act by the release of antimitotic factor(s), appear to be the final effector 
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cells causing the pancytopenia of acute GVHD, which, in turn, may terminate as 
lethal GVHD (7). 2 
In  our  preceding  paper, 2 we  analyzed the  cellular  events  leading  to  acute 
GVHD after the injection into nonirradiated (C57BL/10  ×  DBA/2)Fz  (BDFI) 
recipients of 10 s unseparated spleen cells (SpC) obtained from C57BL/10 (B10) 
donors. After a  brief initial activation of Lyt-1 +2- donor Th cells, beginning in 
week  2,  an  activation  of  F~-specific  Lyt-2  +  donor  Ts  cells  took  place.  The 
occurrence of these alloreactive Ts cells was confined to acute GVHD, in time 
and in the donor-host combinations being compared. In those of the B 10-injected 
BDF~ mice that did not succumb to acute GVHD but instead recovered from it, 
a  gradual  loss  of donor  Ts  cells  took  place.  This  gradual  disappearance  of 
alloreactive donor Ts cells was paralleled in time by a  decrease of the pancyto- 
penia  of acute  GVHD.  By day  60,  the  GVH  F1  mice  showed  hematopoietic 
recovery and exhibited at moderate lymphoid stimulation as well as perivascular 
and periductal  lymphoid infiltrations in  liver and salivary glands. 2 We termed 
this form of chronic GVHD secondary (2 °) chronic GVHD to distinguish it from 
1 ° chronic GVHD, which is not preceded by acute GVHD but directly results in 
a full-blown SLE-like disease (8). ~ 
In the present investigation, we used the B 10 ~  BDF~ model to further analyze 
the transition from acute GVHD to 2 ° chronic GVHD.  We found that most of 
the BDF~ recipient mice that recovered from acute GVHD were repopulated by 
lympho-hematopoietic cells of donor (B 10) origin. Such mice were termed GVH 
F~  chimeras  to  distinguish  them  from  irradiation  chimeras.  The  takeover  in 
GVH F~ chimeras of the lympho-hematopoietic tissue by donor cells was found 
to be  mediated  by the  Lyt-2+-alloreactive donor Ts  cells,  which appear  to be 
relatively short-lived.  In  contrast,  donor  Th  cells  alloactivated in  the  F~  host 
were long-lived; they appeared to mediate the symptoms of 2 ° chronic GVHD. 
Materials and Methods 
Mice.  C57BL/10ScSn (B10) (H-2  b/b, Ig-lbm), B10.D2n (H-2d/~), BDFI (H-2 b/d, Ig-lb/C), 
and B 10 x B 10.BR)F~ (H-2 b/k) mice were purchased from Olac 1976 Ltd., Bicester, Oxon, 
England). BALB/c (H-2 am) and BI0.AKM (H-2 m/m) mice were obtained from the Neth- 
erlands Cancer Institute, Amsterdam. Female mice were used throughout; they were 6- 
10 wk old unless mentioned otherwise. 
Preparatio~ of Donor Cells.  Single-cell  suspensions of donor  SpC,  lymph node cells 
(LNC), and bone marrow cells (BMC) were prepared as described (12). 
Induction  of the  GVHR.  Unless  mentioned otherwise,  the  GVHR  was  induced  by 
intravenous injection of 10  s live B 10 SpC into adult, nonirradiated BDF1 (GVH F~) mice. 
T3'pi~g of Serum Ig-I Allot~,pes.  The procedure of preparing anti-lg-1 allotype serum 
has been described elsewhere (13). Briefly, mice were immunized with pertussis vaccine 
to provide  antipertussis IgG.  At  weekly intervals,  B10  (Ig-1 b/b) pertussis/antipertussis 
agglutinates were injected subcutaneously into DBA/2 (Ig-1 c/c) mice, and vice versa. The 
serum Ig-1 allotypes of individual GVH F~ mice were determined by immunoprecipitation 
in agar gel, by applying the anti-Ig-1 b and -Ig-V allotype sera at constant dilutions of 1:5 
and  1:3,  respectively. At these dilutions of the antiallotype sera, equal endpoint titers 
(1 : 10) of Ig- I b and Ig- 1  c antigen were found in the sera of normal BDF1 (N Fl) mice. The 
anti-Ig-1 c serum could still detect the Ig-1  c antigen provided by one part of N Fl serum 
admixed to nine parts of B10 serum. The sera obtained from GVH F~ mice were assayed 
undiluted. 
Histocompatibilit~, Typing.  An anti-H-2  b serum was prepared in BI0.D2 mice, and an 510  SPLIT TOLERANCE  OF  DONOR  T  CELLS  1N  2 °  CHRONIC GVHD 
anti-H-2  a serum was prepared in  B10  mice, by injecting lymphoid cells  from B10  and 
B10.D2, respectively. Cells of GVH F1 mice were typed by a complement (C)-dependent 
cytotoxicity assay, and the results were expressed as a cytotoxic index (12).  Histocompat- 
ibility typing of erythrocytes was performed by an indirect Coombs' test by applying the 
two antisera  mentioned  above and  a  rabbit anti-mouse  IgG serum (cat.  code  OTPN; 
Behring Werke AG, Marburg/Lahn, Federal Republic of Germany), diluted  1:100. 
Preparation of T  Cell-depleted SpC (B cells).  B cells were prepared by incubating SpC 
with monoclonal anti-Thy-l.2 (clone F7D5; Olac 1976 Ltd.) and C (12).  The percentages 
of live T lymphocytes after treatmentwith anti-Thy-1.2 and C were determined by indirect 
immunofluorescence  by  using  a  rabbit  anti-mouse  brain  serum  in  combination  with 
fluorescein isothiocyanate-labeled anti-rabbit IgG (F2190; Dakopatts, Copenhagen, Den- 
mark); the percentage ofT cells spared by the anti-Thy-l.2 treatment did not exceed 2%. 
Preparation of Nylon-Wool-pur~ed  T Cells.  T  ceil-enriched populations (T cells)  were 
prepared by passing SpC, or SpC plus LNC, through nylon wool (14). 
Anti-Lyt Treatment.  Cell suspensions depleted of Lyt subsets were prepared as described 
elsewhere  (11).  Briefly,  SpC  were  treated  twice  with  either  a  1:1,000  diluted  mouse 
monoclonal anti-Lyt-l.2 (IgG2b) (NEI-017; New England Nuclear,  Boston, MA) and C 
or  a  I:I,000  diluted  mouse  monoclonal  anti-Lyt-2.2  (IgM)  (NEI-006;  New  England 
Nuclear) and C. After the cells were treated with either normal mouse serum (NMS) plus 
C, anti-Lyt-2.2 plus C,  or anti-Lyt-l.2 plus C,  live T  cells comprised 35,  20,  and  4%, 
respectively, of the total number of live SpC. The ability and/or inability of the respective 
cell populations to induce allohelp and/or allosuppression in vitro and in vivo has been 
described elsewhere (11).  The term Lyt-l-2  ÷ cells is an operational one, as defined by 
treatment with anti-Lyt-l.2 plus C; it does not preclude the possible existence of a low 
concentration of Lyt-l.2 on the so-called Lyt-l-2  + cells. 
Primary, Anti-Sheep  Erythrocyte (SE) Response In  Vitro.  Allohelper  and  allosuppressor 
activities of GVH FI  SpC were assayed as described by Pickel and Hoffman (15),  with 
some modifications.  ~ Briefly, a constant number of 5 ×  106 B cells or SpC obtained from 
N  F~  mice or control mice were co-cuhured with increasing numbers of SpC or T  cells 
obtained from GVH F~ mice; 5 ×  105 SE were added as the antigen. On day 4, the direct 
plaque-forming cell  (PFC)  responses  of triplicate  cultures  were  determined  by Jerne 
plaque assay. 
Mixed Lymphocyte Reactions (MLR).  MLR were performed as described elsewhere (16). 
Briefly, MLR were set up in four replicate cultures with 5 ×  105 responder and 7.5 ×  105 
1,500  rad-irradiated  stimulator cells per well.  The MLR were incubated for 4  d,  and 
[SH]thymidine was present during the last 4 h. 
Cell-mediated Lymphocvtotoxicit~, Assay (CML).  The CML activity of SpC was determined 
as described (12). Briefly, responder cells (12 ×  106) were incubated for 5 d together with 
3,300  rad-irradiated  stimulator cells (12  ×  106) in  5 ml of culture medium. The CML 
activity of the cultures was measured in a 4-h chromium-release assay using concanavalin 
A blasts as target cells.  Results are expressed as lytic units (LU) per culture (17), one LU 
being equal to the number of responder cells that gives 25% specific lysis of the target 
cell population. 
Popliteal Lymph Node (PLN) Assay.  The PLN assay was performed as described (18). 
On  day  10 after the  injection of donor SpC into one hind footpad of a  nonirradiated 
recipient mouse, both  PLN  were removed and  weighed.  The strength of the reactive 
PLN enlargement was calculated as the PLN index, being the ratio of the lymph node 
weight from the injected side over that from the noninjected side. For the measurement 
of B  cell  stimulation  in  a  PLN,  cell  suspensions were  prepared from it and  the  total 
number of IgM- and IgG-producing cells per 105 PLN cells was determined by protein A 
PFC assay. 
Protein A PFC Assay.  This assay was performed as described elsewhere (19). 
Assay for the Mortalih, Induced by Transferred GVH F~ SpC.  At the age of ~3 mo, the 
prospective recipient mice were given a lethal 950 rad whole-body irradiation, delivered 
by 662 kV gamma rays emitted from a ~VCs source at a dose of 375 rad/min. Within 3 h 
after irradiation, the mice were injected intravenously with the donor cells indicated. On PALS,  GLEICHMANN, AND  GLEICHMANN  511 
days 1-7 after irradiation, the mice received drinking water that contained polymyxin B 
(I 2,500 U/liter) and oxytetracycline (100 mg/liter). Mice were inspected twice a week for 
symptoms of acute GVHD or death. 
Irradiation  Chimeras.  Untreated BDF1  mice, ~3  mo old, were submitted to 950 tad 
whole-body irradiation  and given antibiotics as described above.  The mice were then 
injected with 107 live B 10 BMC that had been treated with monoclonal anti-Thy-l.2 and 
C.  No  deaths  due  to  GVHD were  observed in  the  recipients.  About  3  mo after the 
repopulation, the FI recipients were tested by histocompatibility typing. More than 95% 
of their SpC were found to be of B10 origin; these irradiation chimeras were used for 
further studies. 
Results 
Complete  Lympho-hematopoietic  Repopulation  of Nonirradiated  BDFI  Recipients  by 
BIO SpC.  A  systemic GVHR  was induced  in groups of BDF1  recipient mice by 
injecting 108 B 10 SpC. As reported earlier (2, 12), 2 at 2-6 wk after the induction 
of GVHR,  the  GVH  F~  mice  invariably  showed  symptoms of acute  GVHD, 
including weight loss, cellular depletion of the lympho-hematopoietic tissue, and 
anemia. The percentage of GVH FI that succumbed to acute GVHD, however, 
varied from experiment to experiment,  the mortality ranging from 20 to 80%. 
The survivors of acute GVHD recovered and no longer showed clinical symptoms 
of GVHD. 
In three groups of GVH  F~  mice that had survived for >100  d, the presence 
of donor  cell  chimerism  was  assayed.  This  was  done  by  determining  the  Ig 
allotype(s) present in the sera of the GVH FI mice and typing their erythrocytes 
for the  presence of H-2  b and  H-2  a antigens.  In  70-80%  of the  GVH  FI  mice 
tested  (Table  I), neither  the  host-derived  Ig-1 ¢ allotypic markers in  the  serum 
nor the  H-2  d alioantigens on the  erythrocytes were detectable.  In contrast,  the 
Ig-1 b allotype and  H-2  b antigens,  which  are  common to both  host  and  donor, 
were  readily  detectable  in  all  these  GVH  FI  mice  (Table  I).  These  findings 
indicate that  most of the  GVH  F~  mice that had  recovered from acute  GVHD 
were repopulated by lympho-hematopoietic cells of donor origin.  In a  group of 
TABLE  I 
Demonstration of Lympho-hematopoietic Takeover by B IO Donor Cells (Ig-1  b/b, H-2  b/b) in the 
Majority of GVH Fl Mice Surviving Acute GVHD 
Number of mice with indicated Ig-1 allo-  Number of mice with indicated H-2 anti- 
Experi-  type in the serum*/number tested  gens on their erythrocytes0/number tested 
ment*  Day 100  Day 200  Day 100  Day 200 
Ig-1  b  Ig-Y  Ig-1  b  Ig-1  c  H-2  b  H-2  d  H-2  b  H-2  d 
1  32/32 j  8/32  31/31  7/31  32/32  8/32  31/3t  7/31 
2  29/291  9/29  --~  --  29/29  8/29  --  -- 
3  38/381  11/38  --  --  38/38  11/38  --  -- 
* Each group of BDFI recipients consisted initially of 40 mice. 
* An Ig-1 allotype was considered to be lacking when it was not detectable in the undiluted serum 
by the Ouchterlony test. 
i The sensitivity of the applied indirect Coombs' test was such that the anti-H-2  d serum still detected 
one part of BDF~ erythrocytes mixed to four parts of B10 erythrocytes, 
b  ! The lg-1 allotype in these mice was still detectable at a serum dilution of 1:10. 
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GVH  F,  mice  that  were autopsied  at  day  100  after  the  induction  of GVHR, 
repopulation was confirmed by histocompatibility typing of their SpC (Table II). 
From the same GVH F~ mice, we also typed cell suspensions consisting of either 
BMC, thymus cells, or LNC: whereas the cytotoxic indices obtained after treat- 
ment with the host-specific anti-H-2 d serum and C were 3,  1, and 2, respectively, 
those obtained with anti-H-2 b serum and C were 98, 94, and 97. 
H-2 typing of the spleens of GVH F~  mice killed at regular  intervals showed 
that host cells had almost completely disappeared from their spleens as early as 
day  14  after  induction  of GVHR  (Table  II).  The  rapid  disappearance  of the 
host-derived  Ig-I c allotype from  the  sera  of another  group  of GVH  F1  mice 
(Table  II) agrees  with  this  observation.  Once established,  the  repopulation  of 
GVH F1 mice was a stable condition in that it lasted for at least 200 d (Table I). 
Lympho-hematopoietie  Repoputatio~  of Nonirradiated BDFI Recipients Is Mediated by 
Non-Lyt-separated  Alloreactive  T  Cells.  Next,  we analyzed  the  cellular  require- 
ments of lympho-hematopoietic takeover. As expected, we found that the injec- 
tion  of 5  x  10 v B10  LNC, a  population  deficient in  hematopoietic  stem cells, 
failed to repopulate,  but caused lethal  GVHD (LGVHD) in  70%  of the  BDF1 
recipients. Whereas GVH mortality in the F, recipients was significantly reduced 
by the addition  of B10 BMC as a  source of stem cells to the inoculum  of B10 
LNC, this was not the case when BMC from BDF~ mice were added to B10 LNC 
(data not shown).  In the next experiment,  we demonstrated that lympho-hema- 
topoietic  repopulation  was  mediated  by unseparated  alloreactive  B10  T  cells 
(Table III). First, three groups of BDF~ mice were injected with  108 live cells of 
one of the following sources: (a) B10 SpC, pretreated with NMS and C, (b) B10 
SpC, pretreated with anti-Thy-1.2 and C, or (c) SpC obtained from B 10 ~  BDF1 
irradiation  chimeras.  The SpC obtained from irradiation  chimeras were shown 
to  be  specifically  tolerant  of  BDFl  antigens  in  both  MLR  (Table  IV)  and 
allogeneic T-B cell cooperation (Fig.  1). At about day 100 after the induction of 
GVHR, we determined whether the host-specific Ig-1 ~ allotype was still  present 
in sera from the recipients. In contrast to B 10 SpC pretreated with N MS, neither 
anti-Thy-l.2-pretreated  B10  SpC  nor  B10  SpC  that  were  tolerant  of BDFI 
recipients were able to cause the lympho-hematopoietic repopulation (Table III). 
TABLE  II 
Kinetics of Lympho-hematopoietic Takeover b~, BIO Donor Cells (Ig-I b/b, H-2  b/b) in GVH F~ Mice 
Antiserum 
Method  used 
Time after the induction of the GVHR (days) 
0  7  14  28  60  100  150 
Number of positive animals/number tested 
Typing of Ig-1  Anti-lg-1  c  10/10  --*  10/10  2/10  2/10  2/10  2/10 
allotypes in  Anti-Ig-1  b  10/10  --  10/10  10/10  10/10  10/10  10/10 
serum 
Mean cytotoxic index* 
C-dependent cy-  Anti-H-2  d  95  56  6  2  -2  2  1 
totoxic test  Anti-H-2  b  98  91  99  97  97  92  94 
*  Not tested. 
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TABLE  III 
Lympho-hem~dopoietic Repopulatio~ Requires Unseparated Alloreactive Donor 
T Cells 
513 
Donor SpC* 
Number of BDF~ recipients  * 
with indicated Ig-1 allotype 
in the serum/number tested 
Mice  Pretreatment  Ig- lb  Ig-I ~ 
B10  NMS +  C  15/15  2/15 
B10  Anti-Thy-1.2 + C  15/15  15/15 
Irradiation chimeras  None  15/15  15/15 
B10  Anti-Lyt-l.2 + C  14/14  14/14 
B10  Anti-Lyt-2.2 + C  15/15  15/15 
* 108 live SpC were injected. 
* Each group initially consisted of 15 mice; they were tested at about day 100 
after the injection of donor cells. 
TABLE  IV 
MLR Respol~ses of GVH F~ Chimera Cells Exposed to Various Stimulator Cells 
Responder cells  Mean cpm obtained with stimulator cells indicated* 
GVH Ft  (BI0 x 
Mice  Cell type  ~  BI0  chimera  BDFI  BI0.BR)  BIO.D2  BI0.AKM 
Day 100 after induction of GVHR 
B  10  SpC  370  787  13,730  8,966  14,416  17,303 
B I 0  T ceils  214  546  | 14,660  64,375  62,711  91,834 
GVH Ft chimera|  SpC  678  987  29,141  12,918  22A17  22,336 
GVH Fi chimera  T cells  458  739  104,865  32,285  57,202  76,052 
Irradiation chimera  SpC  513  --!  563  5,640  --  6,329 
Irradiation chimera  T  cells  1,114  --  1,135  55,342  --  93,400 
Day 210 after induction of GVH  R 
B 10  T cells  438  399  137,467  45,771  64,555  121,380 
GVH FI chimera  T cells  744  671  5,433  28,173  5,588  51,538 
* For the sake of readability,  standard deviations  are not shown; they never exceeded  10% of the mean values. 
* In each group, T  cells were prepared by pooling SpC and LNC obtained from four mice and passing them over nylon wool. 
! GVH F~ SpC were pooled from four mice. 
! Not tested. 
To  determine  which  T  cell  subpopulations  were  involved,  we  then  injected 
groups  of BDF1  recipients with  cells  from B10  SpC  that  had  been pretreated 
with either anti-Lyt-l.2 and C  or anti-Lyt-2.2 and C.  Neither anti-Lyt-l.2- nor 
anti-Lyt-2.2-pretreated B 10 SpC were able to repopulate the F1 recipients (Table 
III).  Thus,  lympho-hematopoietic  repopulation  of  nonirradiated  BDFI  mice 
required inocula containing alloreactive B10 T  cells that had not been separated 
into Lyt subsets and, in addition, included syngeneic (B10) stem cells. 
Persistence in Long-term  GVH F I Chimeras of F ~-specific Donor  Th Cells.  Next, we 
analyzed the functional properties of cells derived from the long-term GVH F1 
chimeras.  Unless indicated otherwise, the experiments described in this section 
and all subsequent sections were performed with SpC that were obtained from 
GVH  FI  chimeras killed at day  100-150  after the induction of GVHR.  These 
SpC consisted of >95% B 10 donor cells. First, we studied whether B10 Th cells, 
obtained from GVH F1 chimeras, could still react against host-type alloantigens. 514  SPLIT  TOLERANCE OF  DONOR T  CELLS IN  2  ° CHRONIC GVHD 
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FIGURE  I.  Helper activity in  the  spleens of GVH  FI  chimeras  killed ~I00  d  after  the 
induction of GVHR. SpC obtained from a GVH FI chimera provide allohelp to BDF, B cells 
(A), but only syngeneic  help to B10 B cells (B). The SpC titrated to the SE-stimulated  B cell 
cultures were obtained frond (@) a B10 mouse, (Ig) an irradiation chimera, (O) a GVH F~ 
chimera, (I-7) an N Fj mouse. 
This was done by measuring the effects of SpC from GVH F~ chimeras on the 
primary anti-SE response, in vitro, of B cells syngeneic either to the host (BDF~) 
or to the GVH donor (B10).  Graded numbers of SpC obtained from GVH FI 
chimeras, normal B10  or BDF~ mice, or B10 ---) F~  irradiation chimeras were 
added to SE-stimulated B cell cultures. The results of such an experiment are 
shown in  Fig.  1;  they are  representative of six identical experiments, each of 
which  was  done  using  SpC  from an  individual GVH  F~  chimera.  Essentially 
similar results were obtained when nylon-wool-purified T  cells  instead of SpC 
were used (data not shown). The addition of low numbers of normal B10 SpC 
to semiailogeneic BDF~ B cells led to a positive allogeneic effect (Fig. 1 A), which 
is  known  to  be  caused  by  Lyt-l+2--alloreactive Th  cells  (20,  21).  When  the 
number of normal B10 SpC was further increased, a negative allogeneic effect 
occurred, caused by Lyt-2÷-alloreactive Ts cells  (20,  21).  The addition of low 
numbers of SpC obtained from GVH F1 chimeras to the BDF~ B cells led, as did 
the addition of normal B10  SpC,  to a  positive aliogeneic effect. However, no 
negative allogeneic effect ensued after the addition of high numbers  of SpC 
from the GVH F~ chimeras. These findings indicate that host-specific donor Th 
ceils  were still  present in the spleens of long-term GVH F~ chimeras, whereas 
alloreactive Ts cells were no longer detectable. The loss of alloreactive Ts cell 
activity from the spleens of GVH F~ chimeras (day 100) was also apparent in the 
observation that they failed to suppress, but instead slightly stimulated, the anti- 
SE PFC response of N  F~ SpC (Fig. 2).  For comparison, the suppressive effects 
resulting from co-culture of N F~ SpC and GVH F~ SpC obtained at days 10 and 
38 after the induction of GVHR are shown (Fig. 2). 
T Cells of Long-term GVH F~ Chimeras Show Split  Tolerance Towards Host Alloan- 
tigens.  Next, we examined whether the SpC of GVH F1 chimeras were able to PALS,  GLEICHMANN,  AND  GLEICHMANN  515 
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FIGURE 2.  Suppressor activity in the spleens of BDF1 recipients at various times after the 
induction of GVHR. (O) 10 d, (r-l) 38 d, or (I) 100 d (GVH Fi chimera) after the induction of 
GVHR with B10 SpC. Results are expressed are the percentage of PFC in control cultures 
(1,860 PFC/culture)  to which no GVH Fl SpC were added.  Results representative  of five 
identical experiments are shown. 
respond in MLR and CML to host or third-party  ailoantigens.  GVH F~ chimera 
cells, obtained at day  100 after the induction  of GVHR, responded to host-type 
and third-party alloantigens with about equal strength (Table IV). At 210 d after 
the induction  of GVHR, GVH F~  chimera  cells still showed a  significant,  albeit 
reduced, response against host-type alloantigens (Table IV). Thus, donor T  cells, 
able to proliferate  in  response  to host-type alloantigens,  did persist in GVH  F~ 
chimeras  for at least 6  mo.  In marked  contrast,  the T  cells obtained from these 
long-term GVH Fa chimeras showed hardly any CML activity after restimulation 
with  irradiated  host-type  (BDFI)  cells  (Table  V).  Out  of  the  total  of  seven 
individually tested GVH F~ chimeras,  five showed no detectable CML activity at 
all,  and  two others  showed only a  very weak CML activity.  As is evident  from 
Table  V,  the  lack  of CML  activity  against  host-type  alloantigens  was  specific. 
SpC  obtained  from  GVH  F~  chimeras  did  not  suppress  the  anti-BDFa  CML 
response of N  B10 SpC (Table V). This indicates  that a  lack of cytotoxic T  cell 
precursors  rather  than  the presence  of suppressor  cells was responsible  for the 
specific inability of GVH Fl chimeras to generate T  killer (Tk) cells against host- 
type alloantigens. 
T Cells ofBlO --~ F1 Irradiation Chimeras Are Completely Tolerant of the Host.  We 
then  asked  whether  the  type  of split  tolerance  found  in  long-term  GVH  F~ 
chimeras  also  existed  in  irradiation  chimeras,  as  stated  by  Sprent  et  al.  (22). 
Evidently,  it did not, however, because SpC obtained from irradiation  chimeras 
showed neither allohelper (Fig. 1) nor proliferative activity (Table IV) in response 
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TABLE  V 
CTL Respol~sive~less of SpC Obtained  from GVH FI Chimeras 
Mean number 
Responder SpC  Target cells  of LU/culture 
4- SEM 
Bl0*  BDFI  688 ___ 110 
B10*  (B10 x  B10.BR)FI  483 +  72 
GVH Fl chimera  :~  BDFI  8 4- 5 
GVH F~ chimera*  (B10 X B10.BR)F~  503 +  114 
B10 +  GVH F~ chimera  §  BDF~  555 I 
555 
BI0 +  GVH F~ chimera  ~  (B10 X B10.BR)Ft  555 I 
1,100 
* Cells obtained from seven normal B10 mice that were tested individually. 
* Cells  obtained  from  seven  GVH  F~  chimeras  that  were  tested  individually; 
these mice were taken at da~gs 100-120 after the induction of the GVHR. 
J Mixtures containing 8  x  10Onormal B10 SpC and 4  ×  106/SpC obtained from 
a  GVH FI  chimera were co-cultured for 5  d  in MLR. Two GVH F1 chimeras 
were studied; they had been taken from the group of seven chimeras described 
in footnote * 
I Results of two individual experiments. 
GVH Reactiviv  of Adoptively  Tra~sferred  SpC  Obtai~ed from  Long-term  GVH FI 
Chimeras.  Having  demonstrated  the  split  tolerance  of GVH  chimera  cells  in 
vitro,  we then  examined  their  ability to  react against  host alloantigens  in  two 
GVH assays in vivo, the PLN assay and the GVH mortality assay. First, we asked 
whether the B10 T  cells present in GVH chimeras were still able to cause PLN 
enlargement as well as B cell activation when confronted with BDF~ alloantigens. 
Both types of reactivity were indeed found.  Moreover, both the  PLN enlarge- 
ment and  the B cell activation were caused by cells reacting specifically against 
the DBA/2 part of the BDFl recipients (Table VI). More than 95% of the total 
Ig secretion induced in the PLN was of the IgG isotype. 
Then  we tested  the  ability of GVH  F~  chimera  SpC  to  induce  mortality  in 
lethally irradiated BDF1 recipients. To avoid mortality due to a hypothetical lack 
of hematopoietic stem cells in the donor cell inoculum,  the SpC obtained from 
tile  GVH  F~  chimeras  were  mixed  with  BMC  from  the  same  mice.  The  cell 
suspensions  thus  obtained  did  not  contain  detectable  numbers  of BDFI  cells, 
whereas the  percentage  of T  cells in  the  cell  mixture  was similar  to that  in  a 
mixture  prepared  from normal  B10 Spc plus BMC. The injection of 30  X  106 
GVH F~ chimera cells into 950 tad-irradiated  BDF1 recipients did not lead to a 
significant  incidence  of LGVHD;  9  out  of  l0  recipients  survived  for  >80  d 
(Table VII, group 4) without showing symptoms of secondary disease. At day 80 
after  the  cell  transfer,  the  sera  of these  secondary  BDF~  recipients  contained 
only the  Ig-1 b allotype,  indicating  that  they were repopulated  by donor  (B10) 
cells. As expected, all  BDF1 recipients of normal B10 SpC died within 40 d after 
the induction of GVHD (Table VII, group  1). The inability of GVH F~ chimera 
cells to induce GVH mortality in  irradiated  BDF~ recipients  was specific, since 
(B10  X B10.BR)FI  recipients all  succumbed within  30 d  after the  injection  of 
GVH F~ chimera cells (Table VII, group 5). The mixture of GVH Fl SpC with 
BI0 SpC did not affect the ability of the latter cells to induce LGVHD in BDFI PALS,  GLEICHMANN,  AND  GLEICHMANN 
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Cells transferred  Nonirradiated recipient mice* 
Number  Mean PLN in-  Donor  Strain  (x 106)  dex ±  SEM. 
Number of IgG protein A 
PFC/10  ~ PLN cells 
Test-side PLN  Contra-lat- 
eral PLN 
B10  5  BDF~  2.3 ±  0.4*  39 ±  15  <5 
10  5.2 ±  0.8  t  76 ±  10  <5 
15  5.0 ±  0.8  !  158 ±  50  7 +  3 
B10  15  BI0  1.4 _  0.2  <5  <5 
GVH F11  5  BDF1  3.5 _+ 0.8  !  142 --+ 58  <5 
chimera  10  3.4 ±  0.7  !  161  _+ 86  5 _+ 2 
15  5.8 ±  0.3 t  331  ±  97  18 ±  6 
GVH F~ I  15  B10  1.4 ±  0.1  <5  <5 
BDF~  15  BDF~  1.7 ±  0.1  <5  <5 
* Four mice per group. 
* P <  0.05 as compared with the syngeneic control. 
0 p  <  0.005 as compared with the'syngeneic control. 
i Pooled SpC from 20 GVH F~ chimeras were used; these mice were taken at about 
day 100 after the induction of the GVHR. Cells from this same pool were used in the 
mortality assay (Table VII). 
recipients (Table  VII,  group  7).  Thus,  a  lack of relevant alloreactive T  cells, 
rather than  the  presence of suppressor  cells,  was responsible  for the  specific 
inability of the SpC obtained from GVH F~ chimeras to induce GVH mortality 
in lethally irradiated BDF1 recipients. 
Discussion 
Recent papers  from this  laboratory have reported  that  SLE-like GVHD  in 
nonirradiated F~  mice is caused by Lyt-l+-2  -  donor Th cells that react against 
class II (I-A/I-E) alloantigens of the host (3,  11, 23). Induction of acute GVHD, 
by contrast, required unseparated donor T cells (11). In acute GVHD, apparently 
there is a  sequential alloactivation consisting of first (week  1) class II-reactive 
Lyt-l+2  - donor cells that subsequently (weeks 2 to 6) induce class I (K/D)-reactive 
Lyt-l+2  +  and  Lyt-l-2  +  allosuppressor  effector cells  (3,  11,  24,  25). 2  When 
unseparated SpC of the donor B I 0 were injected into fully H-2-different BDF1 
mice, the following three stages of GVHR  were distinguished: (a) In week  1, 
alloactivated donor Th cells predominated; (b) from weeks 2 to 6, donor Ts cells 
prevailed and caused acute GVHD; and (c) in those GVH F1 mice that survived 
that stage of acute GVHD, alloreactive donor Ts cells were no longer detectable 
(Fig.  2) and the stimulatory pathological symptoms of 2 °  chronic GVHD ap- 
peared (8). 2 In the present investigation, we extended the functional analysis of 
B10 donor T  cells obtained from F~ recipients with 2 ° chronic GVHD. 518  SPL1T TOLERANCE  OF  DONOR  T  CELLS IN  2 °  CHRONIC  GVHD 
TABLE VII 
Mortality in Lethally Irradiated Recipients Injected Intravenously with SpC Plus BMC Obtained 
from Either Normal Donors or GVH FI Chimeras 
Cells transferred*  950 rad-irradiated recipients 
Num- 
Group  Donors  Source  ber (x  Strain 
10  ~) 
Cumulative mortality at day: 
20  40  80 
1  B10  SpC +  20  BDFt  6/10  I0/10  10/10 
BMC  10 
2  B10  SpC +  20  (B10 x B10.BR)FI  7/10  10/10  10/10 
BMC  10 
3  B10  SpC +  20  B10  2/10  2/10  2/10 
BMC  10 
4  GVH FI*  SpC +  20  BDF~  1/10  1/I0  1/10 
chimera  BMC  10 
5  GVH Fl*  SpC +  20  (B10 x B10.BR)F~  4/10  10/10  10/10 
chimera  BMC  10 
6  GVHF~*  SpC +  20  B10  1/10  1/10  1/10 
chimera  BMC  10 
7  B10  SpC +  20  BDF~  5/5  5/5  5/5 
BMC +  10 
GVH FI*  SplC  10 
chimera 
8  None  --  --  BDFt  10/10  I0/10  10]10 
* Pooled SpC from 20 GVH Fl chimeras were used; these mice were taken at about day 100 after 
the induction of GVHR. BMC were pooled from the same mice. 
Repopulation ofF1 Recipients by Lympho-hematopoietic  Donor Cells.  Several groups 
of investigators have observed that nonirradiated H-2-different F1 mice undergo- 
ing GVHR may be repopulated by parental SpC (26-28). The recent observation 
(2) that such a repopulation took place in parent ~  Fl combinations undergoing 
acute GVHD, but not as readily in GVH F1 mice developing a chronic lupus-like 
GVHD, prompted us to further analyze the relationship between acute GVHD 
and  lympho-hematopoietic repopulation.  A  likely possibility was  that  the  Lyt- 
1+2 + and  Lyt-l-2  +  Frspecific donor Ts cells (24,  25,  29), 2 whose presence in 
GVH  F1  mice shortly preceded and coincided with the pancytopenia of acute 
GVHDfl did indeed mediate the depletion of lympho-hematopoietic host cells. 
Alternatively, the appearance of the donor Ts cells might be an epiphenomenon 
secondary to the disappearance of lympho-hematopoietic host cells, a  situation 
analogous to the secondary appearance of Ig allotype-specific Ts cells observed 
after the preceding deprivation of that allotype (30). Our results favor the former 
possibility. Repopulation was only achieved by the injection into BDF1 recipients 
of unseparated B 10 SpC, but not of either Lyt-1+2  -  or Lyt-1-2  + B 10 SpC alone. 
Moreover, the unseparated B 10 T  cells required for repopulation had to be able PALS,  GLEICHMANN,  AND  GLEICHMANN  519 
to react towards the host (Table III). Thus, the complete lympho-hematopoietic 
repopulation described in the present paper appears to be mediated by the same 
alloactivated donor Ts cells that cause acute GVHD and the pancytopenia that 
accompany it (2, 3, 7,  11). 2 
Split Tolerance  Towards Host Alloantigens in Survivors of Acute GVHD.  Up till 
now, only limited studies on the anti-F~  reactivity of donor T  cells present in 
nonirradiated GVH Fl chimeras have been performed (27, 28). We found that 
Fl-specific donor Ts cells (Fig.  1) and Tk cells (Table V) were not at all, or were 
hardly any longer detectable in the spleens of long-term GVH F~ chimeras. In 
marked contrast,  Fi-specific donor Th  cells (Fig.  1),  as well as  MLR-reactive 
donor T  cells (Table IV), were readily recovered from the GVH  F~  chimeras 
until at least 5 mo after the induction of GVHR. This split tolerance of the B10 
T  cells recovered from long-term GVH chimeras was also demonstrable in vivo: 
whereas the B10 T  cells obtained from GVH chimeras had specifically lost their 
capacity to induce LGVHD in secondary BDFI recipients (Table VII), they were 
still able to induce F~-specific PLN enlargement and B cell activation (Table VI). 
These findings conform to other observations showing that PLN enlargement 
(S. T. Pals, unpublished observation) and B cell activation in vivo (3, 11, 23) can 
be initiated by alioreactive Th cells alone. In contrast, acute GVHD requires a 
sequential activation of alioreactive Th and Ts ceils (3,  11). 2 An interpretation 
in immunogenetic terms of the observed split tolerance strongly suggests that 
ailoreactivities,  such  as  CML  (31-33),  allosuppression  (3,  20,  21),  and  acute 
GVHD  (3),  in  which  class  I  (K/D)  antigens  provide  the  main  targets,  were 
seriously impaired  in  the donor  T  cells that  were recovered from long-term 
GVH  F~ chimeras. By contrast, alloreactivities, such as MLR (32-34), allohelp 
(3, 20, 21, 23), and B cell activation (3), that are mainly directed against class II 
alloantigens, remained unimpaired over several months. According to this inter- 
pretation, the stimulatory phenomena observed in 2 ° chronic GVHD (2) 2 were 
caused by the long-lived donor Th cells that must have reacted against a minor 
population  of persisting  Fa  cells  carrying class  II  alloantigens.  Another,  not 
mutually exclusive, explanation for the stimulatory pathological phenomena in 
2 ° chronic GVHD might be that  late-acting donor Th  cells reacted to class  I 
alloantigens,  or  yet  other  antigens,  that  they recognized in  association  with 
syngeneic (donor) class II structures (35). 
The same kind of split tolerance that we observed here in long-term GVH F~ 
chimeras was reported by Sprent et al.  (22) in lethally irradiated F~ mice that 
had been reconstituted with parental BMC pretreated with anti-Thy-l.2 and C. 
In contrast, we found no evidence for the presence of anti-host-reactive T  cells 
in such irradiation chimeras (Fig.  1, Table IV). Consistent with our observation, 
complete tolerance of donor T  cells towards the host has also been described in 
fully allogeneic irradiation chimeras (36). The discrepancy between our findings 
and those of Krown et al. (36) on the one hand, and those of Sprent et al. (22) 
on the other, might lie in a  failure of the latter investigators to remove all the 
mature T  cells from the donor BMC by the conventional anti-Thy 1.2 they used. 
Our findings and those of Krown et ai. (36) both fit the concept that radioresistant 
host cells determine the self-specificity of immature donor T  cells differentiating 
in an allogeneic host (37,  38).  Correspondingly, our findings indicate that the 520  SPLIT  TOLERANCE  OF  DONOR  T  CELLS  IN  2 °  CHRONIC  GVHD 
allohelper T  cells recovered from the long-term GVH F~ chimeras were derived 
from the mature donor T  cells injected for the induction of GVHR. 
To  explain  the  development  of split  tolerance  of donor  T  cells  in  GVH 
chimeras, at least three possibilities had to be considered: (a) There might have 
been an active suppression of the anti-F~-reactive Ts/Tk clones. Although it has 
been  observed  that  T  cells  obtained  from  radiation  chimeras  can  specifically 
suppress the anti-host reactivity of donor T  cells (39, 40), there was no evidence 
for  such  a  mechanism  in  our  GVH  F1  chimeras  (Table  V  and  VII),  (b)  the 
sequential alloactivation  in acute GVHD first of donor Th and then  of Ts cells 
follows the rules of the T  cell feedback circuit (41). Conceivably, the activation 
of donor Ts cells might have been quenched because of a reduction of T  helper/ 
inducer activity which,  in turn,  resulted from a  numerical decrease in GVH F1 
chimeras of stimulatory (class II) alloantigens.  However, when the B10 cells that 
were  recovered  from  long-term  GVH  F~  chimeras  were  reexposed  to  BDF1 
stimulator cells, either in vitro or in vivo, no reactivation of Ts/Tk cells ensued, 
although  vigorous allohelper and  MLR responses were obtained.  (c) The early 
loss of Ts/Tk cell activity may be due to a  rather  short lifespan  of these cells. 
This possibility is supported by other observations (42, 43; E. K61sch,  personal 
communication) that the time periods during which activated Ts cells remained 
detectable were relatively short,  whereas the longevity of activated Th  cells is 
well established (44). 
Whatever the mechanism of the observed split tolerance may be, our findings 
clearly indicate that anti-host-reactive  donor Th cells can persist in the host for 
at  least  6  mo.  These  findings  challenge  the  role  of donor  T  cells  in  chronic 
GVHD as proposed by Elkins (45).  He argues that  the role of donor T  cells in 
chronic GVHD might be merely to trigger, during the stage of acute GVHD, a 
number of pathogenic  effects, such as immunosuppression,  infection, and acti- 
vation of latent viruses. These secondary GVH effects would then, independently 
of donor T  cells, cause the symptoms of chornic GVHD. Although we are aware 
of these GVH effects, our findings suggest that long-lived alloreactive donor Th 
cells can directly cause and maintain  most of the stimulatory pathological symp- 
toms of 2 ° chronic GVHD.  In this context,  it is noteworthy that  cells obtained 
from  human  patients  with  chronic  GVHD,  but  not  those  without  GVHD, 
responded to HLA-identical, cryopreserved host cells in an MLR (39, 46). 
Summary 
We studied the alloreactive properties of donor T  cells obtained from F~ mice 
that  had  recovered  from  the  allosuppression  of  acute  graft-vs.-host  disease 
(GVHD) and showed mild symptoms of chronic GVHD, i.e., so-called secondary 
chronic  GVHD.  To this  end,  we used  (B10  x  DBA/2)F1  mice  that  had  been 
injected  with  108  B10 spleen  cells  100-150  d  previously.  Such  GVH  F~  mice 
were repopulated  by lympho-hematopoietic cells of donor (B10) origin,  which 
exhibited split tolerance towards the host:  Whereas  Fl-specific donor T  helper 
(Th) cells as well as T  cells proliferating in the mixed lymphocyte reaction were 
readily demonstrable,  Fl-specific T  suppressor (Ts) and T  killer (Tk) cells were 
not, or were hardly,  detectable; responses against third-party alloantigens were 
normal.  Upon adoptive transfer to nonirradiated  secondary recipients, the B10 PALS, GLEICHMANN, AND  GLEICHMANN  521 
ceils obtained from the repopulated GVH FI  mice induced F~-specific enlarge- 
ment of the draining popliteal lymph node and enhancement of the IgG forma- 
tion therein. B10 cells of the same kind were unable, however, to induce lethal 
GVHD upon transfer to 950 rad-irradiated secondary (B10 X DBA/2)FI  recipi- 
ents. We conclude that alloactivated donor Ts/Tk cells disappear from the host 
at a relatively early stage of GVHD, i.e., at the end of acute GVHD, presumably 
because  they are  short-lived.  By contrast,  the  longevity of alloactivated donor 
Th cells causes the symptoms of secondary chronic GVHD. 
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